🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase IIa trial compares the safety and effect of temozolomide combine...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-10-15
Trial ID
NCT06202066
This phase II trial compares the effect of sacituzumab govitecan and bevaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-10
Trial ID
NCT07504588
This phase Ib trial tests the safety and tolerability of ZEN003694 in combi...
Status
Recruiting
Location
Boston Medical Center
Start Date
2023-05-18
Trial ID
NCT05422794
This phase I trial tests the safety, side effects, and best dose of triapin...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2025-07-30
Trial ID
NCT06860594
This phase II trial tests how well giving CIMAvax-EGF with KRAS G12C inhibi...
Status
Not Yet Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-09-01
Trial ID
NCT07543172
This phase I/II trial studies the side effects and the best dose of uproser...
Status
Completed
Location
USC / Norris Comprehensive Cancer Center
Start Date
2013-10-08
Trial ID
NCT01902173
This trial studies how well an imaging technique called magnetic resonance ...
Status
Completed
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-31
Trial ID
NCT06090630
Treatments Being Tested
This phase I trial studies the side effects and best dose of savolitinib in...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2018-11-27
Trial ID
NCT03598244
Treatments Being Tested
This trial studies how well 68-Ga RM2 works with PET/MRI in imaging patient...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-03-19
Trial ID
NCT03831711
Checkpoint inhibitor-related pneumonitis (CIP) is a common fatal immune-rel...
Status
Recruiting
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2026-01-10
Trial ID
NCT07340892